In general, CD44 mRNA was expressed more abundantly in the healthy urothelium than in bladder tumors and showed a trend to decrease with the severity of the disease (Figure 1 A).
← all excerpts
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
1
—
—